We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
-20.16%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$1.22B
AUM Growth
+$25.2M
Cap. Flow
+$287M
Cap. Flow %
23.51%
Top 10 Hldgs %
5.22%
Holding
1,483
New
378
Increased
381
Reduced
313
Closed
382

Top Buys

Rank Stock Value
1
ASAN icon
Asana
ASAN
+$8.41M
2
MRVL icon
Marvell Technology
MRVL
+$8.25M
3
GFS icon
GlobalFoundries
GFS
+$7.98M
4
NFLX icon
Netflix
NFLX
+$7.87M
5
ZBRA icon
Zebra Technologies
ZBRA
+$7.48M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$6.39M
2
TTD icon
Trade Desk
TTD
+$6.28M
3
XYL icon
Xylem
XYL
+$6.22M
4
GILD icon
Gilead Sciences
GILD
+$6.21M
5
UAA icon
Under Armour
UAA
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 21.57%
2 Healthcare 15.01%
3 Industrials 12.49%
4 Financials 12.17%
5 Consumer Discretionary 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYH icon
951
Community Health Systems
CYH
$393M
$166K 0.01%
+44,377
New +$313K
ACRS icon
952
Aclaris Therapeutics
ACRS
$726M
$165K 0.01%
11,799
+33
+0.3% +$462
CUE icon
953
Cue Biopharma
CUE
$113M
$165K 0.01%
2,205
+406
+23% +$47.5K
QNCX icon
954
Quince Therapeutics
QNCX
$22.9M
$163K 0.01%
367
+234
+176% +$165K
PMVP icon
955
PMV Pharmaceuticals
PMVP
$59.2M
$161K 0.01%
+11,316
New +$165K
EVC icon
956
Entravision Communication
EVC
$1.03B
$158K 0.01%
34,576
-13,808
-29% -$70.9K
LAUR icon
957
Laureate Education
LAUR
$5.28B
$157K 0.01%
+13,551
New +$161K
FULC icon
958
Fulcrum Therapeutics
FULC
$273M
$154K 0.01%
+31,438
New +$307K
DXLG icon
959
Destination XL Group
DXLG
$31.2M
$153K 0.01%
45,263
+12,728
+39% +$57.3K
MCW
960
DELISTED
Mister Car Wash
MCW
$152K 0.01%
14,012
-94,063
-87% -$1.22M
KBAL
961
DELISTED
Kimball International
KBAL
$150K 0.01%
19,521
-1,819
-9% -$14.9K
SEAT icon
962
Vivid Seats
SEAT
$84.6M
$149K 0.01%
+1,001
New +$181K
TE
963
T1 Energy
TE
$1.16B
$149K 0.01%
+21,778
New +$191K
OPAD icon
964
Offerpad Solutions
OPAD
$18.3M
$146K 0.01%
+447
New +$300K
TCRR
965
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$146K 0.01%
50,275
-16,779
-25% -$41.4K
CFB
966
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$145K 0.01%
10,969
-3,652
-25% -$49.2K
SND icon
967
Smart Sand
SND
$185M
$142K 0.01%
+70,934
New +$245K
RRGB icon
968
Red Robin
RRGB
$145M
$141K 0.01%
17,522
+3,086
+21% +$33.3K
LENZ
969
LENZ Therapeutics
LENZ
$166M
$141K 0.01%
+7,320
New +$163K
SRTS icon
970
Sensus Healthcare
SRTS
$47.9M
$140K 0.01%
18,190
+4,830
+36% +$40.5K
DTIL icon
971
Precision BioSciences
DTIL
$180M
$138K 0.01%
2,866
-256
-8% -$15K
PVL
972
Permianville Royalty Trust
PVL
$57.1M
$137K 0.01%
41,080
+5,483
+15% +$20.5K
FRBK
973
DELISTED
Republic First Bancorp Inc
FRBK
$136K 0.01%
35,697
-13,171
-27% -$56.2K
CTOS icon
974
Custom Truck One Source
CTOS
$2.31B
$135K 0.01%
24,021
-6,160
-20% -$39.3K
TRHC
975
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$135K 0.01%
52,430
-75,529
-59% -$283K
37 38
39
40 41

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return

Occudo Quantitative Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Occudo Quantitative Strategies held 1,483 positions worth $1.22B, up 2.1% from $1.19B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Occudo Quantitative Strategies deployed $287M of net new capital in Q2 2022, opening 378 new positions and adding to 381 existing holdings. Its largest new stake was Marvell Technology: 145,519 shares worth $6.33M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Sherwin-Williams, an estimated $5.12M trimmed.

  • Occudo Quantitative Strategies's largest Q2 2022 buy was Marvell Technology: 145,519 shares worth $6.33M.
  • Occudo Quantitative Strategies added most to Asana in Q2 2022, an estimated $8.41M increase.
  • Occudo Quantitative Strategies's biggest Q2 2022 reduction was Sherwin-Williams, cutting an estimated $5.12M.
  • Occudo Quantitative Strategies fully exited 3M in Q2 2022, selling an estimated $6.39M.
  • Occudo Quantitative Strategies's ten largest holdings make up 5.2% of its $1.22B portfolio in Q2 2022.
  • Occudo Quantitative Strategies opened 378 new positions and closed 382 in Q2 2022.
  • Occudo Quantitative Strategies's portfolio value rose 2.1% quarter-over-quarter to $1.22B.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.